Noteworthy Numbers
Biologic drugs, which include therapeutic proteins and monoclonal antibodies, are large complex molecules typically manufactured in genetically engineered organisms.
Neutropenia is characterized by low levels of neutrophils, the white blood cells that fight infections. In general, the condition is defined as an absolute neutrophil count (ANC) <1500/μL. There are several factors that can contribute to the development of neutropenia, including idiopathic and congenital etiologies, as well as some cancers, such as leukemia, myeloma, and lymphoma. However, one of the most common causes of neutropenia is the use of chemotherapy. The following provides a brief look at some of the key statistics regarding this condition.
Since 1980, the incidence of liver and intrahepatic bile duct cancer has more than tripled in the United States, whereas the death rates have more than doubled during this time.
Until the late 1930s, stomach cancer—also called gastric cancer—was the leading cause of cancer death in the United States. Although stomach cancer is still a major cause of cancer-related deaths worldwide, it is now much less common in this country. The following provides a brief look at some of the key statistics regarding this disease.
Ovarian cancer is a very difficult disease to diagnose and is the most lethal gynecologic malignancy, being the fifth leading cause of cancer death in women in the United States.
Skin cancer is the most frequently diagnosed malignancy in the United States. Although invasive melanoma comprises approximately 1% of skin cancers, it is the cause of a vast majority of skin cancer–related deaths. The following provides helpful information related to this malignancy.
Ovarian cancer affects the glands found in women that produce eggs, known as ova, for reproduction. The American Cancer Society estimates that 22,240 women will be diagnosed with new cases of ovarian cancer in 2018, and 14,070 women will die from the disease during the same year.
Patients with indolent subtypes of NHL have a relatively good prognosis with a median survival as long as 20 years, although these subtypes of the disease are typically not curable in advanced stages.
Peripheral neuropathy is the result of damage to the peripheral nervous system, the complex network of nerves that transmits messages between the brain and other parts of the body. Such damage can cause impaired movement, loss of sensation in the arms and legs, numbness, tingling, and pain.
